Because of the cytoprotective power Hsp70 reduces the sensitivity of tumors to anti-cancer drugs (such as doxorubicin, etoposide, cisplatin, and others collectively known to induce apoptosis)2, an effective therapy should be at least partially based on targeting chaperone activity in cancer cells. Here, HSPA1A is linked to cancer.